Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions.

Messoud AshinaDavid KudrowUwe ReuterDavid DolezilStephen D SilbersteinStewart J TepperFei XueHernan PicardFeng ZhangAndrea WangYanchen ZhouFrank HongJan KlattDaniel D Mikol

Published in: Cephalalgia : an international journal of headache (2019)

ClinicalTrials.gov NCT01952574, NCT02483585, NCT02456740, NCT02066415, and NCT02174861.

Keyphrases

placebo controlled
double blind
open label
genome wide
clinical trial
copy number
squamous cell carcinoma
phase iii
gene expression
radiation therapy
dna methylation